Journal of Pharmaceutical Innovation

, Volume 9, Issue 2, pp 106–114 | Cite as

Study of Dissolution Kinetics for Poorly Water-Soluble Drugs from Ternary Interactive Mixtures in Comparison with Commercially Available Capsules

  • Ayman Allahham
  • Hamzah M. Maswadeh
Research Article



The main objective of this work was to study the dissolution kinetics of poorly water-soluble drugs, indomethacin and ibuprofen, from formulated capsules or interactive mixtures containing fine lactose (FL), as ternary additive, and coarse lactose as carrier compared with selected commercially indomethacin capsules and to investigate the role of FL-drug size ratio on the dissolution.

Results and Discussion

It was found that the addition of FL in lactose-indomethacin capsules enhanced the dissolution of indomethacin while it has decreased the dissolution of ibuprofen from the lactose-ibuprofen mixtures. The particle size distributions for drugs and fine lactose used in this study suggested that the difference in dissolution behaviour for the two drugs could be due to the FL-drug ratio. Results obtained from the application of different dissolution kinetic equations showed that the first-order equation can best describe the kinetic of the dissolution for Rothacin®, Indylon®, Indomin® and ternary-formulated capsules of indomethacin, while the dissolution from the binary-formulated indomethacin capsules showed that the dissolution cannot be described by zero-order or first-order equations. For ibuprofen mixtures, the results showed that the release followed the first-order kinetic for both systems, binary and ternary mixtures. Results obtained from Peppas equation showed that all indomethacin formulations used in this study released the drug by Fickian release with release exponent (n) <0.45, while all ibuprofen formulations used in this study released the drug by non-Fickian (anomalous) release with release exponent (n) >0.45 and >0.89.


The FL-drug ratio could give an explanation to the enhanced dissolution of indomethacin and decreased dissolution of ibuprofen from interactive mixtures.


Indomethacin Ibuprofen Ternary interactive mixture Dissolution kinetics 



This study was funded by a grant from the Deanship for Research in Qassim University. In addition, the authors would like to acknowledge the Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO, Qassim, KSA) for giving access to its particle sizer (Mastersizer 2000). The authors would like to acknowledge Mr. Mohammad Al-Massidi and Mr. Abdelmajeed Al-Habeeb for their contribution in the lab during the conduction of this study.


  1. 1.
    Abrahamsson B, Lennernas H. Application of biopharmaceutic classification system now and in the future. In: Waterbeemd HVD, Lennernas H, Artursson P, editors. Drug bioavailability. Weinheim: Wiley Inter. Science; 2003. p. 495–531.Google Scholar
  2. 2.
    Banakar UV. Pharmaceutical dissolution testing. 1st ed. New York: Marcel Dekker; 1992.Google Scholar
  3. 3.
    Lauwo JAK. Effect of particle size and excipients on the dissolution rate of metronidazole from solid dosage forms (II). Drug Dev Ind Pharm. 1984;10:1085–96.CrossRefGoogle Scholar
  4. 4.
    Charoenchaitrakool M, Dehghani F, Foster NR, Chan HK. Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind Eng Chem Res. 2000;39:4794–802.CrossRefGoogle Scholar
  5. 5.
    Perrut M, Jung M, Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes: part I: micronization of neat particles. Int J Pharm. 2005;288(1):3–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Andreou JG, Stewart PJ, Morton DAV. Short-term changes in drug agglomeration within interactive mixtures following blending. Int J Pharm. 2009;372(1–2):1–11.PubMedCrossRefGoogle Scholar
  7. 7.
    Bolten D, Türk M. Micronisation of carbamazepine through rapid expansion of supercritical solution. J Supercrit Fluids. 2012;62:32–40.CrossRefGoogle Scholar
  8. 8.
    Pinto EC, Carmo FA, Honório TD, Barros R, Castro HCR, Rodrigues CR, et al. Influence of the efavirenz micronization on tableting and dissolution. Pharmaceutics. 2012;4(3):430–41.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Rasenack N, Mueller BW. Micron-size drug particles: common and novel micronization techniques. Pharm Dev Technol. 2004;9:1–13.PubMedCrossRefGoogle Scholar
  10. 10.
    Stewart PJ. Particle interaction in pharmaceutical systems. Pharm Int. 1986;7:146–9.Google Scholar
  11. 11.
    Verraes J, Kinget R. Ordered powder mixing: theory and practice. Int J Pharm Technol Prod Manuf. 1980;1:36–41.Google Scholar
  12. 12.
    McGinity JW, Ku CT, Bodmeier R, Harris MR. Dissolution and uniformity properties of ordered mixes of micronized griseofulvin and a directly compressible excipient. Drug Dev Ind Pharm. 1985;11:891–900.CrossRefGoogle Scholar
  13. 13.
    Nystrom C, Westerberg M. The use of ordered mixtures for improving the dissolution rate of low solubility compounds. J Pharm Pharmacol. 1986;38:161–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Westerberg M, Jonsson B, Nystroem C. Physicochemical aspects of drug release (IV): the effect of carrier particle properties on the dissolution rate from ordered mixtures. Int J Pharm. 1986;28:23–31.CrossRefGoogle Scholar
  15. 15.
    De Villiers MM, Van der Watt JG. Interactive mixing between agglomerated drug particles and coarse carrier particles. Drug Dev Ind Pharm. 1989;15:2055–61.CrossRefGoogle Scholar
  16. 16.
    Supabphol R, Stewart PJ. Influence of the carrier on the intrinsic rate of dissolution of diazepam in interactive mixtures. J Pharm Pharmacol. 1996;48:1249–55.PubMedCrossRefGoogle Scholar
  17. 17.
    Nilsson P, Westerberg M, Nystroem C. Physicochemical aspects of drug release (V): the importance of surface coverage and compaction on drug dissolution from ordered mixtures. Int J Pharm. 1988;45:111–21.CrossRefGoogle Scholar
  18. 18.
    Westerberg M, Nystroem C. The usefulness of ordered mixtures in drug formulation of a solid dosage form. Congr Int Technol Pharm. 1989;1:278–87.Google Scholar
  19. 19.
    Shah NH, Phuapradit W, Bachynsky M, Infeld MH, Iqbal K, Malick AW. High energy ordered mixture for improving the dissolution rate of sparingly soluble compounds. Drug Dev Ind Pharm. 1994;20:873–88.CrossRefGoogle Scholar
  20. 20.
    Supabphol R, Stewart PJ. Aggregation during the dissolution of diazepam in interactive and granulated mixtures. Pharm Pharmacol Commun. 1996;2:233–6.Google Scholar
  21. 21.
    Westerberg M, Nystroem C. Physicochemical aspects of drug release (XVII): The use of a surfactant and a disintegrant for improving drug dissolution rate from ordered mixtures. STP Pharm Sci. 1993;3:142–7.Google Scholar
  22. 22.
    Stewart P, Alway B. Aggregation during the dissolution of diazepam in interactive mixtures. Part Sci Technol. 1995;13:213–26.CrossRefGoogle Scholar
  23. 23.
    Liu J, Stewart P. Deaggregation during the dissolution of benzodiazepines in interactive mixtures. J Pharm Sci. 1998;87(12):1632–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Thiel WJ, Nguyen LT, Sberna FJ. Content uniformity of microdose tablets (dosage 1 microgram-10 mg) produced by fluid bed granulation of interactive mixtures. J Pharm Pharmacol. 1986;38:335–43.PubMedCrossRefGoogle Scholar
  25. 25.
    Adi H, Larson I, Chiou H, Youn P, Traini D, Stewart P. Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation. Pharm Res. 2006;23:2556–65.PubMedCrossRefGoogle Scholar
  26. 26.
    Allahham A, Stewart P. The effect of lactose properties on the in vitro dissolution of micronised indomethacin from interactive mixtures. Chemeca. Brisbane: Australia. 2005; Abstract no 154: p 99Google Scholar
  27. 27.
    Allahham A, Stewart P. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose. Eur J Pharm Biopharm. 2007;67(3):732–42.PubMedCrossRefGoogle Scholar
  28. 28.
    The United States Pharmacopeia 32 / National Formulary 27, Physical Tests and Determinations, General Chapter <711>: Dissolution, Vol. 1, The United States Pharmacopoeial Convention, Rockville, 2005Google Scholar
  29. 29.
    Baveja SK, Range RKV, Singh A, Gombar VK. Release characteristics of some bronchodilators from compressed hydrophilic polymeric matrices and their correlation with molecular geometry. Int J Pharm. 1988;41(1–2):55–62.CrossRefGoogle Scholar
  30. 30.
    Najib N, Suleiman M. Dissolution profiles of long-acting quinacrine hydrochloride pellets (II). Drug Dev Ind Pharm. 1985;11(12):2155–68.CrossRefGoogle Scholar
  31. 31.
    Dortunc B, Gunal N. Release of acetazolamide from swellable HPMC matrix tablets. Drug Dev Ind Pharm. 1997;23:1245–9.CrossRefGoogle Scholar
  32. 32.
    Buckton G, Ganderton D, Shah R. In vitro dissolution of some commercially available sustained-release theophylline preparations. Int J Pharm. 1988;42:35–9.CrossRefGoogle Scholar
  33. 33.
    Ritger PL, Peppas NA. A simple equation for description of solute release from swellable devices. J Control Release. 1987;5:37–42.CrossRefGoogle Scholar
  34. 34.
    Lopes CM, Lopes JF, Costas P, Pinto JF. Compressed mini-tablets as a biphasic delivery system. Int J Pharm. 2006;323:93–100.PubMedCrossRefGoogle Scholar
  35. 35.
    Romero AJ, Grady LT, Rhodes CT. Dissolution testing of ibuprofen tablets. Drug Dev Ind Pharm. 1988;14(11):1549–86.CrossRefGoogle Scholar
  36. 36.
    Stippler E, Kopp S, Dressman JB. Comparison of US Pharmacopeia Simulated Intestinal Fluid TS (without pancreatin) and Phosphate Standard Buffer pH 6.8, TS of the International Pharmacopoeia with respect to their use in in vitro dissolution testing. Dissolut Technol. 2004;11(2):6–10.Google Scholar
  37. 37.
    Otsuka M, Tomita H, Otsuka K, Kamae I, Jorgenson JA. International harmonization of generic drugs: in vitro dissolution tests for Japanese and American generic tablets. Biomed Mater Eng. 2006;16(2):129–35.PubMedGoogle Scholar
  38. 38.
    Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note. AAPS Pharm Sci Technol. 2007;8(1):94–9.CrossRefGoogle Scholar
  39. 39.
    Rivera-Leyva JC, García-Flores M, Valladares-Méndez A, Orozco-Castellanos LM, Martínez-Alfaro M. Comparative studies on the dissolution profiles of oral ibuprofen suspension and commercial tablets using biopharmaceutical classification system criteria. Indian J Pharm Sci. 2012;74(4):312–8.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Adi H, Larson IC, Stewart PJ. Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation. Eur J Pharm Sci. 2009;36(2–3):265–74.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Pharmaceutics, College of PharmacyQassim UniversityBuraydahSaudi Arabia
  2. 2.Department of Pharmaceutics, College of Pharmacy and DentistryBuraydah Private CollegesBuraydahSaudi Arabia

Personalised recommendations